English
Insider transactions
EDGARCARGO Therapeutics, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-21.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
This issuer has insider filings in the store, but no transaction in this window or code group.
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Samsara BioCapital, L.P. Common Stock, par value $0.001 | 0.0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001699737-25-000017 Dispute this row |
| Samsara BioCapital GP, LLC Common Stock, par value $0.001 | 0.0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001699737-25-000017 Dispute this row |
| Srinivas Akkaraju Common Stock, par value $0.001 | 0.0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001699737-25-000017 Dispute this row |
| Madison Avenue Partners, LP Common stock, par value $0.001 per share (the "Common Stock") | 0 | 0 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001013594-25-001412 Dispute this row |
| Madison Avenue International LP Common stock, par value $0.001 per share (the "Common Stock") | 0 | 0 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001013594-25-001412 Dispute this row |
| EMAI Management, LLC Common stock, par value $0.001 per share (the "Common Stock") | 0 | 0 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001013594-25-001412 Dispute this row |
| Madison Avenue GP, LLC Common stock, par value $0.001 per share (the "Common Stock") | 0 | 0 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001013594-25-001412 Dispute this row |
| Caraway Jackson Investments LLC Common stock, par value $0.001 per share (the "Common Stock") | 0 | 0 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001013594-25-001412 Dispute this row |
| Eli Samaha Common stock, par value $0.001 per share (the "Common Stock") | 0 | 0 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001013594-25-001412 Dispute this row |
| RTW Investments, LP Common stock, par value $0.001 per share | 0.0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001493215-25-000039 Dispute this row |
| Roderick Wong Common stock, par value $0.001 per share | 0.0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001493215-25-000039 Dispute this row |
| Nextech VII GP S.a. r.l. Common Stock, $0.001 par value | 0.0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001916892-25-000005 Dispute this row |
| Nextech VII Oncology SCSp Common Stock, $0.001 par value | 0.0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001916892-25-000005 Dispute this row |
| Ian Charoub Common Stock, $0.001 par value | 0.0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001916892-25-000005 Dispute this row |
| Costas Constantinides Common Stock, $0.001 par value | 0.0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001916892-25-000005 Dispute this row |
| Rocco Sgobbo Common Stock, $0.001 par value | 0.0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001916892-25-000005 Dispute this row |
| TANG CAPITAL MANAGEMENT, LLC Common Stock, par value $0.001 per share | 100 | 10,000.00 | 08/19/2025 Filed 2025-08-21 | SCHEDULE 13D/AAmendment 2 | Open filing 0001214659-25-012545 Dispute this row |
| KEVIN TANG Common Stock, par value $0.001 per share | 100 | 10,000.00 | 08/19/2025 Filed 2025-08-21 | SCHEDULE 13D/AAmendment 2 | Open filing 0001214659-25-012545 Dispute this row |
| TANG CAPITAL PARTNERS, LP Common Stock, par value $0.001 per share | 100 | 10,000.00 | 08/19/2025 Filed 2025-08-21 | SCHEDULE 13D/AAmendment 2 | Open filing 0001214659-25-012545 Dispute this row |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP Common Stock, par value $0.001 per share | 0 | 0.00 | 08/19/2025 Filed 2025-08-21 | SCHEDULE 13D/AAmendment 2 | Open filing 0001214659-25-012545 Dispute this row |
| TANG CAPITAL PARTNERS III, INC Common Stock, par value $0.001 per share | 0 | 0.00 | 08/19/2025 Filed 2025-08-21 | SCHEDULE 13D/AAmendment 2 | Open filing 0001214659-25-012545 Dispute this row |
| TANG CAPITAL PARTNERS IV, INC Common Stock, par value $0.001 per share | 0 | 0.00 | 08/19/2025 Filed 2025-08-21 | SCHEDULE 13D/AAmendment 2 | Open filing 0001214659-25-012545 Dispute this row |
| CONCENTRA BIOSCIENCES, LLC Common Stock, par value $0.001 per share | 100 | 10,000.00 | 08/19/2025 Filed 2025-08-21 | SCHEDULE 13D/AAmendment 2 | Open filing 0001214659-25-012545 Dispute this row |
| CONCENTRA MERGER SUB VII, INC. Common Stock, par value $0.001 per share | 0 | 0.00 | 08/19/2025 Filed 2025-08-21 | SCHEDULE 13D/AAmendment 2 | Open filing 0001214659-25-012545 Dispute this row |
| FMR LLC COMMON STOCK | 0.0 | 7,196.00 | 07/31/2025 Filed 2025-08-07 | SCHEDULE 13G/AAmendment 4 | Open filing 0000315066-25-002179 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 0.0 | 7,196.00 | 07/31/2025 Filed 2025-08-07 | SCHEDULE 13G/AAmendment 4 | Open filing 0000315066-25-002179 Dispute this row |
| TANG CAPITAL MANAGEMENT, LLC Common Stock, par value $0.001 per share | 6.6 | 3,059,630.00 | 07/07/2025 Filed 2025-07-09 | SCHEDULE 13D/AAmendment 1 | Open filing 0001214659-25-010211 Dispute this row |
| KEVIN TANG Common Stock, par value $0.001 per share | 6.6 | 3,059,630.00 | 07/07/2025 Filed 2025-07-09 | SCHEDULE 13D/AAmendment 1 | Open filing 0001214659-25-010211 Dispute this row |
| TANG CAPITAL PARTNERS, LP Common Stock, par value $0.001 per share | 3.7 | 1,720,894.00 | 07/07/2025 Filed 2025-07-09 | SCHEDULE 13D/AAmendment 1 | Open filing 0001214659-25-010211 Dispute this row |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP Common Stock, par value $0.001 per share | 2.9 | 1,338,736.00 | 07/07/2025 Filed 2025-07-09 | SCHEDULE 13D/AAmendment 1 | Open filing 0001214659-25-010211 Dispute this row |
| TANG CAPITAL PARTNERS III, INC Common Stock, par value $0.001 per share | 0 | 0.00 | 07/07/2025 Filed 2025-07-09 | SCHEDULE 13D/AAmendment 1 | Open filing 0001214659-25-010211 Dispute this row |
| TANG CAPITAL PARTNERS IV, INC Common Stock, par value $0.001 per share | 0 | 0.00 | 07/07/2025 Filed 2025-07-09 | SCHEDULE 13D/AAmendment 1 | Open filing 0001214659-25-010211 Dispute this row |
| CONCENTRA BIOSCIENCES, LLC Common Stock, par value $0.001 per share | 0 | 0.00 | 07/07/2025 Filed 2025-07-09 | SCHEDULE 13D/AAmendment 1 | Open filing 0001214659-25-010211 Dispute this row |
| Madison Avenue Partners LP Common stock, par value $0.001 per share (the "Common Stock") | 9.1 | 4,193,626 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001013594-25-001008 Dispute this row |
| Madison Avenue International LP Common stock, par value $0.001 per share (the "Common Stock") | 9.1 | 4,193,626 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001013594-25-001008 Dispute this row |
| EMAI Management, LLC Common stock, par value $0.001 per share (the "Common Stock") | 9.1 | 4,193,626 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001013594-25-001008 Dispute this row |
| Madison Avenue GP, LLC Common stock, par value $0.001 per share (the "Common Stock") | 9.1 | 4,193,626 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001013594-25-001008 Dispute this row |
| Caraway Jackson Investments LLC Common stock, par value $0.001 per share (the "Common Stock") | 9.1 | 4,193,626 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001013594-25-001008 Dispute this row |
| Eli Samaha Common stock, par value $0.001 per share (the "Common Stock") | 9.1 | 4,193,626 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001013594-25-001008 Dispute this row |
| RTW Investments, LP Common stock, par value $0.001 per share | 6.4 | 3,055,063.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001415889-25-021704 Dispute this row |
| Roderick Wong Common stock, par value $0.001 per share | 6.4 | 3,055,063.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001415889-25-021704 Dispute this row |
| FMR LLC COMMON STOCK | 15.0 | 6,916,945.00 | 06/30/2025 Filed 2025-08-06 | SCHEDULE 13G/AAmendment 3 | Open filing 0000315066-25-001980 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 15.0 | 6,916,945.00 | 06/30/2025 Filed 2025-08-06 | SCHEDULE 13G/AAmendment 3 | Open filing 0000315066-25-001980 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,687,210 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 103,592 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,828 |
Filings made before the SEC required XML are listed, not extracted.